Primary Serological Status and Immunological Efficacy of Vaccination against Streptococcus Pneumoniae and Haemophilus Influenzae Type b in Children with Bronchopulmonary Dysplasia: a Cohort Study
Background. The primary serological status of children with bronchopulmonary dysplasia (BPD) with respect to respiratory significant pathogens remains unstudied. Wherein, the efficacy of vaccination of children with BPD against Streptococcus pneumoniae and Haemophilus influenzae type b (Hib) has bee...
Saved in:
| Main Authors: | Klavdiia A. Kazakova, S. Leyla Namazova-Baranova, Irina V. Davidova, Yrii S. Akoev, Marina V. Fedoseenko, Natalya E. Tkachenko, Elena G. Filyanskaya, Vasiliy N. Lubov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2018-02-01
|
| Series: | Педиатрическая фармакология |
| Subjects: | |
| Online Access: | https://www.pedpharma.ru/jour/article/view/1592 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extrapulmonary Conditions, Concomitant of Bronchopulmonary Dysplasia, in Babies of the First 3 Years of Life: Results of a Retrospective Cross-Sectional Study
by: K. A. Kazakova, et al.
Published: (2016-12-01) -
Assessment of Safety, Immunogenicity and Preventive Efficacy of Prevenar-13 in Children with Bronchopulmonary Dysplasia
by: E. S. Zubova, et al.
Published: (2018-04-01) -
The Most Important Risk Factors and Associated Morbidities of Bronchopulmonary Dysplasia, the Never Ending Problem of Preterms
by: Ayşen Bayrak, et al.
Published: (2025-08-01) -
PREVENTIVE STRATEGIES IN THE STAGES OF FORMATION AND COURSE OF BRONCHOPULMONARY DYSPLASIA
by: I. V. Davydova, et al.
Published: (2014-03-01) -
The Destructive Cycle in Bronchopulmonary Dysplasia: The Rationale for Systems Pharmacology Therapeutics
by: Mia Teng, et al.
Published: (2025-07-01)